{"schema_version":"1","generated_at":"2026-10-28T06:53:50.269Z","data_as_of":null,"url":"https://www.findmykol.com/kol/carlos-romo","json_url":"https://www.findmykol.com/kol/carlos-romo/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"carlos-romo","name":"Carlos Romo","specialty":"Neurology","specialty_raw":"Neurology","therapeutic_area":"Neurology","therapeutic_areas":["Neurology"],"city":"Baltimore","state":"MD","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1700129913","orcid":"0000-0002-0260-7047","openalex":"A5073650119"},"summary":"Carlos Romo is a Neurology physician. OpenAlex indexes 107 publications with 843 citations (h-index 14); ClinicalTrials.gov lists 4 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Neurology"]},"scholarship":{"works_count":107,"cited_by_count":843,"h_index":14,"latest_activity_year":2025,"emerging":true,"source":"works"},"trials":{"count":4,"shown":3,"withheld":1,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT07102394","title":"Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1","phase":"PHASE1","status":"RECRUITING","role":"Overall official","sponsor":"Johns Hopkins University","source_url":"https://clinicaltrials.gov/study/NCT07102394","trial_url":"https://www.findmykol.com/trial/NCT07102394"},{"nct":"NCT06159166","title":"Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF).","phase":"PHASE1/PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"Johns Hopkins University","source_url":"https://clinicaltrials.gov/study/NCT06159166","trial_url":"https://www.findmykol.com/trial/NCT06159166"},{"nct":"NCT05581511","title":"Natural History Study of Cutaneous Neurofibromas in People With NF1","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"Johns Hopkins University","source_url":"https://clinicaltrials.gov/study/NCT05581511","trial_url":"https://www.findmykol.com/trial/NCT05581511"}],"source":"trials"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":4,"shown":3,"withheld":1,"rows":[{"payer":"Alexion Pharmaceuticals, Inc.","program_year":2025,"amount_usd":51543.23,"payment_count":10,"source_url":"https://openpaymentsdata.cms.gov/search?query=1700129913"},{"payer":"SpringWorks Therapeutics, Inc.","program_year":2025,"amount_usd":3175,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1700129913"},{"payer":"SpringWorks Therapeutics, Inc.","program_year":2024,"amount_usd":7877.36,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1700129913"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1700129913","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent Glioblastoma","year":2025,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1078-0432.ccr-24-2311","status":"verified"},{"title":"Integrated genomic analysis of NF1-associated peripheral nerve sheath tumors: an updated biorepository dataset","year":2025,"journal":"Scientific Data","source_url":"https://doi.org/10.1038/s41597-025-05433-7","status":"verified"},{"title":"Surgical management of schwannomas in schwannomatosis: a comprehensive analysis of clinical outcomes and determinants of local recurrence","year":2025,"journal":"Neurosurgical FOCUS","source_url":"https://doi.org/10.3171/2025.2.focus24751","status":"verified"},{"title":"Phenotypic characterization of neurofibromatosis type 1 in a large Chinese cohort: A cross-sectional study","year":2025,"journal":"JAAD International","source_url":"https://doi.org/10.1016/j.jdin.2025.09.020","status":"verified"},{"title":"Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1","year":2024,"journal":"Neuro-Oncology","source_url":"https://doi.org/10.1093/neuonc/noae235","status":"verified"}],"source":"works"},"contact":{"address_1":"1550 ORLEANS STREET","address_2":"CRB II 1M16","city":"Baltimore","state":"MD","zip":"21287","phone":"410-955-8837","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1700129913","source":"identity"},"similar":[{"name":"Bruce Miller","slug":"bruce-miller","institution":"University of California, San Francisco (UCSF)","specialty":"Neurology","url":"https://www.findmykol.com/kol/bruce-miller","json_url":"https://www.findmykol.com/kol/bruce-miller/profile.json"},{"name":"Brett Kissela","slug":"brett-kissela","institution":"Medical College of Wisconsin","specialty":"Neurology","url":"https://www.findmykol.com/kol/brett-kissela","json_url":"https://www.findmykol.com/kol/brett-kissela/profile.json"},{"name":"Bradley Boeve","slug":"bradley-boeve","institution":"Mayo Clinic","specialty":"Neurology","url":"https://www.findmykol.com/kol/bradley-boeve","json_url":"https://www.findmykol.com/kol/bradley-boeve/profile.json"},{"name":"Richard Lipton","slug":"richard-lipton","institution":"Albert Einstein College of Medicine","specialty":"Neurology","url":"https://www.findmykol.com/kol/richard-lipton","json_url":"https://www.findmykol.com/kol/richard-lipton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":1,"payments":1,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2020-12-11","provider_certified":"2020-12-11","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}